The pharmaceutical industry is undergoing a profound recalibration. After years of pandemic-fueled growth, shifting capital markets, and rapid advances in AI and data science, the pressure to redefine business models has never been greater. Fierce JPM Week brings together the executives shaping this next era, those tasked with balancing innovation, access, and shareholder expectations in a complex, global landscape.

Here, you’ll gain unfiltered insight from peers and partners navigating M&A, policy reform, and the new economics of drug development. The conversations go beyond quarterly results, tackling the strategic moves that will define pharma leadership for the next decade.